Oak Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,125
| Closed | -$966K | – | 137 |
|
|
2020
Q2 | $966K | Hold |
20,125
| – | – | 0.06% | 96 |
|
|
2020
Q1 | $926K | Sell |
20,125
-60
| -0.3% | -$2.76K | 0.08% | 90 |
|
|
2019
Q4 | $1.21M | Hold |
20,185
| – | – | 0.07% | 101 |
|
|
2019
Q3 | $1.14M | Hold |
20,185
| – | – | 0.07% | 97 |
|
|
2019
Q2 | $1.12M | Buy |
20,185
+11,965
| +146% | +$666K | 0.07% | 100 |
|
|
2019
Q1 | $415K | Hold |
8,220
| – | – | 0.03% | 137 |
|
|
2018
Q4 | $331K | Hold |
8,220
| – | – | 0.02% | 146 |
|
|
2018
Q3 | $570K | Hold |
8,220
| – | – | 0.03% | 133 |
|
|
2018
Q2 | $622K | Hold |
8,220
| – | – | 0.04% | 120 |
|
|
2018
Q1 | $433K | Buy |
+8,220
| New | +$433K | 0.03% | 136 |
|